2FIRSTS Attends Dortmund Tobacco Expo 2021 in Germany

Sep.12.2022
2FIRSTS Attends Dortmund Tobacco Expo 2021 in Germany
China's ECCC delegation attend Dortmund tobacco expo; 2FIRSTS PR to report on the latest news.

On September 11 at 22:05 German time (September 12 at 04:05 Beijing time), Jason, the foreign affairs assistant of the Electronic Cigarette Committee of the China Electronic Commerce Association (ECCC) and the PR manager of 2FIRSTS, led the "ECCC International Exhibition Group" to arrive in Dortmund, Germany. They will participate in the Dortmund Tobacco Exhibition from September 15 to 17.


IQOS products sold in the Munich Airport terminal alongside DIGIFLAVOR and ELEAF branded e-cigarettes at airport retail stores.


On September 12th at 9:00 in Germany (15:00 in Beijing), Jason led his team to the Dortmund Exhibition Center, the venue of the current exhibition, to inspect the construction of each booth.


Jason took a photo outside the Dortmund Exhibition Center for commemoration.


The aforementioned information was provided by Jason at 9am local time on September 12. Moving forward, 2FIRSTS will continue to share the latest updates on the Dortmund Tobacco Exhibition through articles, photos, videos and other forms of media.


In the future, 2FIRSTS has plans to report on the electronic cigarette industry in various locations including the UK, Eastern Europe, and Southeast Asia. We will provide you with the latest industry news. Stay tuned.


For more updates on the latest developments of the Tobacco Expo in Dortmund, Germany, please click on the link below.


1. This article is intended solely for internal industry communication and discussion, and does not promote or recommend any specific brands or products. 2. Smoking is harmful to health. Minors are prohibited from reading this article.


This article is an original creation of 2FIRSTS Technology Co., Ltd. in Shenzhen, and its copyright and usage permission belong to the company. No individual or organization is authorized to copy, reprint or use it in any other way without permission, and any infringement of the company's copyright will be subject to legal liability.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Nicotine pouch brand SNÜ launches three fruit flavours, keeps “rub-and-smell” label to reduce retail shrink
Nicotine pouch brand SNÜ launches three fruit flavours, keeps “rub-and-smell” label to reduce retail shrink
UK nicotine pouch brand SNÜ has added three new flavours—Wild Cherry, Cherry Cola and Tropical Punch—spanning multiple nicotine strengths from 9mg to 60mg. The new products also retain the brand’s “rub-and-smell” packaging feature, designed to let shoppers preview the aroma without opening the can and help lower in-store product loss.
Feb.02 by 2FIRSTS.ai
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan (PMJ) said on Jan. 29 it has introduced “Electric Purple” as a new standard color option for its IQOS ILUMA i heated tobacco device lineup, covering three models with prices unchanged. The new color will be available from Jan. 29 via the company’s official online and store channels, with sales expanding to convenience stores and some tobacco retailers from Feb. 3.
Jan.29 by 2FIRSTS.ai
Azerbaijan’s Milli Majlis passes final reading bill banning e-cigarettes and their components
Azerbaijan’s Milli Majlis passes final reading bill banning e-cigarettes and their components
Azerbaijan’s Milli Majlis adopted in final reading a bill banning the import, export, production, storage, wholesale and retail sale, and use of electronic cigarettes and their components, through amendments to the law On Tobacco and Tobacco Products. The document states that nicotine-containing electronic cigarettes are included within the concept of tobacco products and sets out a definition of electronic cigarettes.
Dec.31 by 2FIRSTS.ai
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan has approved amendments to its tobacco law that introduce a comprehensive ban on e-cigarettes and their components, covering import, export, production, storage, wholesale and retail sales, and use. Nicotine-containing e-cigarettes are classified as tobacco products under the revised framework. The law takes effect on April 1, 2026.
Jan.27 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24